Table 2 Clinical characteristics of patients at baseline
Variable | All patients (N = 625) |
|---|---|
Median CD4+ T cell count at baseline (cells/μl) | |
cells/μl [median (IQR)] | 149 (114) |
[calculated on 593/625 pts] | |
CD4 T cell count at baseline | |
-< 50 cells/μl | 88/593 (14.8) |
-> 50 cells/μl | 505/593 (85.2) |
HIV-type infection | |
-HIV-1 | 587/625 (93.9) |
-HIV-2 | 10/625 (1.6) |
-HIV-1 + HIV-2 | 28/625 (4.5) |
WHO clinical stage at baseline | |
-Early (stage 1 and 2) | 309/625 (49.4) |
-Advanced (3 and 4) | 316/625 (50.6) |
HAART regimen | |
-2NRTIs + 1NNRTI | 549/625 (87.8) |
-2NRTIs + 1PI/r | 76/625 (12.2) |
HAART regimen including FDC | |
-Yes | 474/625 (75.8) |
-No | 151/625 (24.2) |